Lazard Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572K | Hold |
|
|||||
|
2025
Q1 | $526K | Sell |
|
|||||
|
2024
Q4 | $465K | Sell |
|
|||||
|
2024
Q3 | $608K | Sell |
|
|||||
|
2024
Q2 | $567K | Sell |
|
|||||
|
2024
Q1 | $574K | Sell |
|
|||||
|
2023
Q4 | $648K | Buy |
|
|||||
|
2023
Q3 | $653K | Sell |
|
|||||
|
2023
Q2 | $728K | Buy |
|
|||||
|
2023
Q1 | $596K | Sell |
|
|||||
|
2022
Q4 | $596K | Sell |
|
|||||
|
2022
Q3 | $602K | Sell |
|
|||||
|
2022
Q2 | $978K | Sell |
|
|||||
|
2022
Q1 | $98.2M | Sell |
|
|||||
|
2021
Q4 | $100M | Buy |
|
|||||
|
2021
Q3 | $92M | Sell |
|
|||||
|
2021
Q2 | $104M | Buy |
|
|||||
|
2021
Q1 | $97.1M | Sell |
|
|||||
|
2020
Q4 | $141M | Sell |
|
|||||
|
2020
Q3 | $162M | Sell |
|
|||||
|
2020
Q2 | $207M | Sell |
|
|||||
|
2020
Q1 | $222M | Buy |
|
|||||
|
2019
Q4 | $234M | Sell |
|
|||||
|
2019
Q3 | $217M | Sell |
|
|||||
|
2019
Q2 | $229M | Sell |
|
|||||
|
2019
Q1 | $243M | Buy |
|
|||||
|
2018
Q4 | $210M | Buy |
|
|||||
|
2018
Q3 | $161M | Buy |
|
|||||
|
2018
Q2 | $138M | Buy |
|
|||||
|
2018
Q1 | $145M | Buy |
|
|||||
|
2017
Q4 | $141M | Buy |
|
|||||
|
2017
Q3 | $136M | Buy |
|
|||||
|
2017
Q2 | $131M | Buy |
|
|||||
|
2017
Q1 | $115M | Sell |
|
|||||
|
2016
Q4 | $159M | Sell |
|
|||||
|
2016
Q3 | $186M | Buy |
|
|||||
|
2016
Q2 | $187M | Buy |
|
|||||
|
2016
Q1 | $162M | Sell |
|
|||||
|
2015
Q4 | $198M | Buy |
|
|||||
|
2015
Q3 | $211M | Buy |
|
|||||
|
2015
Q2 | $219M | Buy |
|
|||||
|
2015
Q1 | $210M | Buy |
|
|||||
|
2014
Q4 | $190M | Sell |
|
|||||
|
2014
Q3 | $193M | Sell |
|
|||||
|
2014
Q2 | $191M | Buy |
|
|||||
|
2014
Q1 | $173M | Buy |
|
|||||
|
2013
Q4 | $149M | Buy |
|
|||||
|
2013
Q3 | $138M | Buy |
|
|||||
|
2013
Q2 | $125M | Buy |
|